South Africa Embolotherapy Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. South Africa Embolotherapy Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. South Africa Embolotherapy Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. South Africa Embolotherapy Market Regional Analysis

6.2 South Africa Embolotherapy Market Revenue 2019-2028 (US$ Million)

6.3 South Africa Embolotherapy Market Forecast Analysis

7. South Africa Embolotherapy Market Analysis – by Product

7.1 Embolic Agents

7.1.1 Overview
7.1.2 Embolic Agents: South Africa Embolotherapy Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.2 Support Devices

7.2.1 Overview
7.2.2 Support Devices: South Africa Embolotherapy Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. South Africa Embolotherapy Market Analysis – by Disease Indication

8.1 Cancer

8.1.1 Overview
8.1.2 Cancer: South Africa Embolotherapy Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.2 Peripheral Vascular Disease

8.2.1 Overview
8.2.2 Peripheral Vascular Disease: South Africa Embolotherapy Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.3 Neurological Diseases

8.3.1 Overview
8.3.2 Neurological Diseases: South Africa Embolotherapy Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.4 Urological & Nephrological Disorders

8.4.1 Overview
8.4.2 Urological & Nephrological Disorders: South Africa Embolotherapy Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.5 Gastrointestinal Disorders

8.5.1 Overview
8.5.2 Gastrointestinal Disorders: South Africa Embolotherapy Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. South Africa Embolotherapy Market Analysis – by Procedure

9.1 Transcatheter Arterial Embolization

9.1.1 Overview
9.1.2 Transcatheter Arterial Embolization: South Africa Embolotherapy Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.2 Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy

9.2.1 Overview
9.2.2 Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy: South Africa Embolotherapy Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.3 Transarterial Chemoembolization

9.3.1 Overview
9.3.2 Transarterial Chemoembolization: South Africa Embolotherapy Market – Revenue and Forecast, 2019-2028 (US$ Million)

10. South Africa Embolotherapy Market Analysis – by End User

10.1 Hospitals & Clinics

10.1.1 Overview
10.1.2 Hospitals & Clinics: South Africa Embolotherapy Market – Revenue and Forecast, 2019-2028 (US$ Million)

10.2 Ambulatory Surgery Centers

10.2.1 Overview
10.2.2 Ambulatory Surgery Centers: South Africa Embolotherapy Market – Revenue and Forecast, 2019-2028 (US$ Million)

10.3 Other End Users

10.3.1 Overview
10.3.2 Other End Users : South Africa Embolotherapy Market – Revenue and Forecast, 2019-2028 (US$ Million)

11. South Africa Embolotherapy Market – South Africa Analysis

11.1 Overview

11.2 South Africa

11.2.1 South Africa Embolotherapy Market Breakdown, by Key Country, 2022 and 2028 (%)
11.2.1.1 South Africa Embolotherapy Market – Revenue and Forecast Analysis – by Country
11.2.1.1 South Africa: South Africa Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.1.1 South Africa: South Africa Embolotherapy Market Breakdown, by Product
11.2.1.1.2 South Africa: South Africa Embolotherapy Market Breakdown, by Disease Indication
11.2.1.1.3 South Africa: South Africa Embolotherapy Market Breakdown, by Procedure
11.2.1.1.4 South Africa: South Africa Embolotherapy Market Breakdown, by End User

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Abbott Laboratories

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 Boston Scientific Corporation

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Cook Medical LLC

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Johnson & Johnson Consumer Inc

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Medtronic

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Acandis GmbH

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Terumo Corporation

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Balt USA LLC

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Stryker Corporation

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 Guerbet LLC.

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

South Africa Embolotherapy Market